Steven Pieper
Directeur Financier/CFO chez XERIS BIOPHARMA HOLDINGS, INC.
Fortune : 658 079 $ au 30/04/2024
Postes actifs de Steven Pieper
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Directeur Financier/CFO | 01/10/2021 | - |
Historique de carrière de Steven Pieper
Anciens postes connus de Steven Pieper
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Catheter Connections, Inc.
 Catheter Connections, Inc. Medical SpecialtiesHealth Technology Catheter Connections, Inc. develops vascular access products. Its flagship product DualCap, designed to protect patients from acquiring infections during intravenous infusion therapy. It disinfects both IV tubing end connectors and needle-free valves. The company was founded by Michael W. Howlett, James Mercer, Vicki Farrar, and Robert Hitchcock in 2008 and is headquartered in Salt Lake City, Utah. | Directeur des opérations | 01/01/2015 | 01/01/2017 |
| Directeur Financier/CFO | 01/01/2015 | 01/01/2017 | |
| DURATA THERAPEUTICS INC | Directeur Financier/CFO | - | - |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Comptroller/Controller/Auditor | 28/07/2021 | - |
| Directeur/Membre du Conseil | 05/10/2021 | - | |
| Directeur Financier/CFO | 28/07/2021 | - | |
| Corporate Officer/Principal | 01/01/2017 | 28/07/2021 |
Formation de Steven Pieper
| DePaul University | Undergraduate Degree |
| Loyola University of Chicago | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Director of Finance/CFO | 4 |
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
Catheter Connections, Inc.
Catheter Connections, Inc. Medical SpecialtiesHealth Technology Catheter Connections, Inc. develops vascular access products. Its flagship product DualCap, designed to protect patients from acquiring infections during intravenous infusion therapy. It disinfects both IV tubing end connectors and needle-free valves. The company was founded by Michael W. Howlett, James Mercer, Vicki Farrar, and Robert Hitchcock in 2008 and is headquartered in Salt Lake City, Utah. | Health Technology |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
- Bourse
- Insiders
- Steven Pieper
- Expérience
